We concluded from the study of basement membrane-associated gene LOXL1 that LOXL1 may decelerate RA synovial inflammation by inhibiting the activation of PI3K/AKT signaling pathway, and LOXL1 may be a potential diagnostic biomarker and therapeutic target for rheumatoid arthritis. Here, AKT1 is linked to rheumatoid arthritis.